A defibrillator is a device used in the healthcare industry for sending an electric pulse or shock to the heart for restoring the normal heartbeat rate. It is utilized for the prevention or correction of arrhythmia. For those who don’t know, arrhythmia is an uneven heartbeat that is either too fast or too slow. In case, if heart suddenly stops beating, defibrillators provide support in restoring the heartbeat. There are various types of defibrillators with varying functionalities.
The automated external defibrillators can be found in public places, led by their wide contribution to saving people’s lives, and those who experience cardiac arrest. Untrained bystanders can also use this equipment in case of emergency.

The North American Defibrillators market is projected to rise in the coming years, accounting for advancements in defibrillation technology, the rising elderly population, and growing incidences of cardiac diseases, along with the rising demand for automated external defibrillators in the region.
Under the product segment, the industry is categorized into ICDs and external defibrillators. The ICDs capture a substantial share, accounting for 55.4% of the industry. Moreover, the external defibrillator is projected to experience faster growth in the coming years, attributed to the growing awareness of the product.
These defibrillators are equipped with stick pads with sensors known as electrodes. These are attached to the patient’s chest. It provides information about the heart rhythm to the computer in the AED. The computer determines if the electric shock is required for analyzing the heart rhythm and if required electrodes give the shock to the patient.
ICDs are sub-categorized into subcutaneous implantable cardioverter defibrillators (S-ICDs) and transvenous implantable cardioverter defibrillators (T-ICDs) Among these, the T-ICDs capture the larger share by product value and volume. T-ICDs are also projected to witness faster growth in the North American industry, led by the rising demand for cardiac resynchronization therapy defibrillators (CRT-Ds) and increasing ICDs adoption by healthcare providers.
The external defibrillators are categorized into manual, automated, and wearable cardioverter defibrillators. Among these, automated defibrillators are projected to capture over $2.5 million in revenue in 2023, accounting for the rising adoption of such products in the residential and public sectors.
Under the end user segment, the North American defibrillators industry is divided into clinics, hospitals, and cardiac centers; pre-hospital care settings, public access settings, and home care settings. The public access setting as end user is projected to experience the fastest growth in the coming future, led by the rising demand for AEDs.
The U.S. is predicted to dominate the North American defibrillators industry. The growing incidences of sudden cardiac arrests, rising penetration of industry players, and surging adoption of AEDs in educational institutes and hospitality settings boost the growth of the U.S. industry.
Therefore, the growing awareness of defibrillators as a life-saving tool for people at risk of cardiac arrest proliferates the industry.